Tamil Nadu govt hospitals face shortage of surfactant drugs for pre-term babies

Several government hospitals across Tamil Nadu are facing a shortage of surfactant medicines, a critical drug used to inflate the lungs of pre-term babies who require the therapy.

Inquiries with a number of hospitals and doctors indicate that multiple centres have been grappling with a short supply of surfactant drugs. The medicine is essential for premature infants whose underdeveloped lungs need assistance to expand and function properly.

The shortage, reported across several government-run facilities, has raised concerns about the availability of a life-saving intervention for newborns in need of respiratory support. Surfactant therapy is a standard treatment for respiratory distress syndrome in pre-term infants, a condition that arises because premature lungs often do not produce enough of the natural substance that keeps air sacs open.

Doctors and hospital sources confirmed that the supply crunch is being felt at a number of centres, though the exact scale and duration of the shortage could not be immediately ascertained. The situation highlights the dependence of government hospitals on a steady supply of specialised neonatal medicines, where any disruption can directly affect care for the most vulnerable patients.

Authorities have not yet issued a public statement on the matter. It remains unclear whether steps are being taken to replenish stocks or to arrange alternative supplies for affected hospitals.